Related Experiment Video
Updated: Jan 14, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
A Hospitalist's Challenge: Systemic Botulism Following a Cosmetic Injection Requiring Antitoxin Therapy and
Parag N Patel1, Fnu Kalpana2, Didar Singh3
1Medicine, Gujarat Medical Education and Research Society (GMERS) Medical College and Hospital, Patan, IND.
Cosmetic botulinum toxin type A (BoNT-A) injections can rarely cause iatrogenic botulism. Prompt recognition and antitoxin therapy are crucial for managing this severe neuromuscular dysfunction following cosmetic procedures.
Area of Science:
- Neurology
- Toxicology
- Dermatology
Background:
- Botulinum toxin type A (BoNT-A) is a common cosmetic treatment.
- Adverse effects are typically localized and transient.
- Rarely, systemic spread or counterfeit products can lead to severe neuromuscular complications.
More Related Videos
Related Concept Videos
Prevention of Further Absorption of Poison
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Skeletal Muscle Relaxants: Therapeutic Uses

